289
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?

, MDORCID Icon, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhDORCID Icon
Pages 713-716 | Received 29 Apr 2020, Accepted 03 Sep 2020, Published online: 07 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gudrun Reitan, Inga Britt Kjellevold Haugen, Kristoffer Andersen, Ragnheidur Bragadottir & Christian Bindesbøll. (2023) Through the Eyes of Patients: Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway. Clinical Ophthalmology 17, pages 1465-1474.
Read now

Articles from other publishers (3)

Khawaja K Shoaib, Muhammad Awaid Abid & Saad Aziz. (2023) Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated. Cureus.
Crossref
Kathrine Blom, Ragnheiður Bragadóttir, Magne Sand Sivertsen, Morten Carstens Moe & Øystein Kalsnes Jørstad. (2021) Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis. Acta Ophthalmologica 100:3.
Crossref
Ningzhi Zhang, Xuejun He, Yiqiao Xing & Ning Yang. (2022) Impact of the COVID-19 pandemic on patients receiving intravitreal injections. Archives of Biological Sciences Arhiv za bioloske nauke 74:1, pages 49-55.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.